Neuroleptic Malignant Syndrome
NEJM 391:1130-1138, Wijdicks,E.F.M. & Ropper,A.H., 2024
Serotonin Syndrome
BMJ 348:g1626, Buckley, N.A.,et al, 2014
The Serotonin Syndrome
NEMJ 352:1112-20, Boyer, E.W. & Shannon, M., 2005
Malignant Hyperthermia, Update on Susceptibility Testing
JAMA 293:2918-2924,2958, Litman,R.S.&Rosenberg,H., 2005
Serotonin Sydrome
Medicine 79:201-209, Mason,P.J. et al, 2000
Acute, Drug-Induced, Life-Threatening Neurological Syndromes
The Neurologist 4:196-210, Richard,I.H., 1998
MDMA (Ecstasy) and the Rave:A Review
Pediatrics 100:705-708, Schwartz,R.H.&Miller,N.S., 1997
Malignant Brain Stem Hyperthermia Caused by Brain Stem Hemorrhage
Stroke 25:518-520, Kitanaka,C.,et al, 1994
Clinicopath Conf
Chronic Idiopathic Anhidrosis, Case 29-1994, NEJM 331:259-265994., , 1994
Fatal Familial Insomnia:Clinical and Pathologic Study of Five New Cases
Neurol 42:312-319, Manetto,V.,et al, 1992
Toxicity and Deaths from 3, 4-Methylenedioxymethamphetamine ("ecstast")
Lancet 340:384-387, Henry,J.A.,et al, 1992
Detecting Susceptibility to Malignant Hyperthermia
BMJ 304:791-792, Ellis,F.R., 1992
Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989
Phenelzine Toxicity Responsive to Dantrolene
Neurol 37:865-867, Verrilli,M.R.,et al, 1987
Neuroleptic Malignant Syndrome:Review and Analysis of 115 Cases
Biol Psychiatry 22:1004-1020, Addonizio,G.,et al, 1987
The Neuroleptic Malignant Syndrome:Agent and Host Interaction
Acta Psychiatr Scand 73:337-347, Shaley,A.&Munitz,H., 1986
Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985
The Malignant Hyperthermia Syndrome
NEJM 309:416-418, Nelson,T.E.,et al, 1983
The Neuroleptic Malignant Syndrome
Arch Int Med 142:1183-1185, Smego,R.A.,et al, 1982
Neuroleptic Malignant Syndrome:A Pathogenetic Role for Dopamine Receptor Blockage
Neurol 31:132-137, Henderson,V.W.,et al, 1981
Phencyclidine Abuse Mimicking Head Injury
JAMA 243:2323-2324, Corales,R.L.,et al, 1980